Browsing Tag: teprotumumab

A 2024 Nature Aging study shows IGF1R inhibitors PPP and NVP-ADW742 extend healthspan by 8–12% but cause GI bleeding and cardiotoxicity, questioning their therapeutic potential. A 2024 mouse study r...